SCHEMBL5781014

SCHEMBL5781014

CCC(c1cc2onc(C)c2c(=O)n1Cc1ccccc1)N(CCCN)C(=O)c1ccc(Br)cc1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784446 0.94 KIF11 (0.68) KIF11
SCHEMBL5787536 0.93 KIF11 (0.66) KIF11
SCHEMBL5792214 0.92 KIF11 (0.64) KIF11
SCHEMBL5784162 0.90 KIF11 (0.64) KIF11
SCHEMBL5806678 0.90 KIF11 (0.62) KIF11
SCHEMBL5786835 0.89 KIF11 (0.60) KIF11
SCHEMBL5786834 0.89 KIF11 (0.60) KIF11
SCHEMBL5803235 0.85 KIF11 (0.65) KIF11
SCHEMBL4040233 0.85 KIF11 (0.88) KIF11
SCHEMBL5784486 0.85 KIF11 (0.58) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628981-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004106492-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-09 WO disclosed